SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001395064-21-000016
Filing Date
2021-01-29
Accepted
2021-01-28 17:57:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sc13ga-012821.htm SC 13G/A 112337
2 EX-99.1 exhibit991-012821.htm EX-99.1 2021
3 EX-99.2 exhibit992-012821.htm EX-99.2 12208
  Complete submission text file 0001395064-21-000016.txt   128083
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Subject) CIK: 0001662774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91007 | Film No.: 21566999
SIC: 2836 Biological Products, (No Diagnostic Substances)